# Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

> **NCT01781741** · EARLY_PHASE1 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 10 (actual)

## Conditions studied

- Recurrent Non-small Cell Lung Cancer
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer
- Stage IV Non-small Cell Lung Cancer

## Interventions

- **COMBINATION_PRODUCT:** therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
- **OTHER:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT01781741
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-06
- **Primary completion:** 2015-11-30
- **Final completion:** 2020-10-14
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781741, "Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01781741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*